NCT02689453
Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL) treatment 1 completed NCT02542124
NM-IL-12 in Cutaneous T-Cell Lymphoma (CTCL) Undergoing Total Skin Electron Beam Therapy (TSEBT) treatment 2 unknown_status NCT01087333
Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment No drug interventions Not Available Not Available recruiting NCT01579318
Phase II Intratumoral IL12 Plasmid Electroporation in Cutaneous Lymphoma treatment 2 terminated NCT06470451
Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL treatment 3 not_yet_recruiting NCT05956041
Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas treatment 2 recruiting NCT05680558
Photopheresis in Early-stage Mycosis Fungoides treatment 2 recruiting NCT03292406
A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL) No drug interventions treatment 2 completed NCT00221039
Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A treatment 4 completed NCT03493451
Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms treatment 2 completed NCT01486277
A Study of the Histone Deacetylase Inhibitor (HDACi) Quisinostat (JNJ-26481585) in Patients With Previously Treated Stage Ib-IVa Cutaneous T-cell Lymphoma treatment 2 completed NCT02593045
Study of IPH4102 in Patients With Relapsed/Refractory Cutaneous T-cell Lymphomas (CTCL) treatment 1 completed NCT02811783
Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL treatment 3 terminated NCT03302728
Brentuximab Vedotin and Lenalidomide in Patients With Relapsed/ Refractory T-cell Lymphoma or Hodgkin Lymphoma treatment 1 completed NCT00099593
Immunization Against Tumor Cells in Sezary Syndrome No drug interventions treatment 2 completed NCT02676778
Study of E7777 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma and Cutaneous T-cell Lymphoma treatment 2 completed NCT05827107
Skin Barrier and Microbiome of CTCL Patients No drug interventions Not Available Not Available enrolling_by_invitation NCT02567656
Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma No drug interventions treatment 1 completed NCT00969085
Trial of Curcumin in Cutaneous T-cell Lymphoma Patients treatment 2 withdrawn NCT00254332
Effect of Denileukin Diftitox on Immune System in CTCL Patients No drug interventions Not Available Not Available completed NCT03116659
CTCL Directed Therapy treatment 0 unknown_status NCT06285370
A Study to Evaluate the Efficacy and Safety of KW-0761 in Chinese Subjects With Mycosis Fungoides or Sézary Syndrome Previously Treated With Systemic Therapy treatment 4 recruiting NCT01578499
A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study) treatment 3 completed NCT02061449
Poly ICLC, Radiation, and Romidepsin for Advanced Cutaneous T Cell Lymphoma treatment 1 terminated NCT00001249
Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) With Yttrium-90 Radiolabeled Anti-Tac treatment 1 completed NCT02881749
Low Dose Total Skin Electron Beam Treatment (TSEBT) Followed by Maintenance Valchlor for Patients With Mycosis Fungoides treatment 2 unknown_status NCT02181218
Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive Lymphomas treatment 1 completed NCT03601819
Pacritinib in Relapsed/Refractory Lymphoproliferative Disorders treatment 1 terminated NCT01134341
Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma treatment 1 completed NCT00779896
Tazarotene 0.1% Cream For the Treatment of Cutaneous T-Cell Lymphoma: A Prospective Study treatment 1 / 2 unknown_status NCT05138458
A Study of MT-101 in Subjects With CD5+ Relapsed/Refractory TCL No drug interventions treatment 1 / 2 suspended NCT02836886
VircapSeq Virus Detection in Sézary Syndrome No drug interventions Not Available Not Available completed NCT06037239
Phase I/II Study of Linperlisib Plus Chidamide for R/R Cutaneous T-cell Lymphoma: a Prospective, Single-center Study treatment 1 / 2 recruiting NCT00341939
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data No drug interventions Not Available Not Available completed NCT03646422
AEDV Registry of Primary Cutaneous Lymphoma No drug interventions Not Available Not Available recruiting NCT03775525
Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer treatment 1 active_not_recruiting NCT04234048
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma treatment 1 recruiting NCT06113081
Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma No drug interventions Not Available Not Available not_yet_recruiting NCT06436677
A Study of Molecular Subtyping-based Therapeutic Strategies for Cutaneous T-cell Lymphoma No drug interventions Not Available Not Available recruiting NCT05414500
Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides treatment 1 recruiting NCT04955340
A Phase 1, Open-label Study of the Absorption, Metabolism, Excretion of [14C]-Resminostat treatment 1 completed NCT05205902
TOtal Skin Electron Beam Therapy (Low-dose) for Tumor Clone Eradication in Early-stage Mycosis Fungoides No drug interventions other 3 not_yet_recruiting NCT05872854
Treatment of Mycosis Fungoides With Hypericin Ointment and Visible Light treatment 2 recruiting NCT05728879
Characterization of the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of APR-TD011® (RLF-TD011®) Spray Solution No drug interventions treatment 0 not_yet_recruiting NCT04045470
A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma No drug interventions diagnostic Not Available recruiting NCT03235869
Radiation Therapy Plus Durvalumab for Tumor-Stage Cutaneous T-Cell Lymphoma treatment 0 withdrawn NCT02539472
Early Diagnosis of Mycosis Fungoides No drug interventions diagnostic Not Available unknown_status NCT02192021
Micro Needle Array-Doxorubicin (MNA-D) in Patients With Cutaneous T-cell Lymphoma (CTCL) treatment 1 completed NCT01676831
Topical Resiquimod for the Treatment of Early Stage Cutaneous T Cell Lymphoma (CTCL) treatment 1 / 2 completed NCT01663571
STAT3 in T Cells: At The Crossroads of Inflammation and Cancer No drug interventions Not Available Not Available terminated NCT01460914
Outcomes of Cutaneous T-Cell Lymphoma and Graft-Versus-Host Disease With Extracorporeal Photopheresis Treatment No drug interventions Not Available Not Available active_not_recruiting NCT01132989
Open-label Pilot Study of Lenalidomide (Revlimid) as Adjuvant Treatment for Refractory Cutaneous T Cell Lymphoma treatment 2 unknown_status NCT00007345
Depsipeptide to Treat Patients With Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma treatment 2 completed NCT03380026
Mechlorethamine Induced Contact Dermatitis Avoidance Study supportive_care 2 completed NCT01433731
Safety, Pharmacodynamics (PD), Pharmacokinetics (PK) Study of SHP141 in 1A, 1B, or 2A Cutaneous T-Cell Lymphoma (CTCL) treatment 1 completed NCT04998331
A Spanish Medical Record Review of Adults With Relapsed or Refractory CD30+ Malignancies When Re-treated With Brentuximab-vedotin No drug interventions Not Available Not Available completed NCT00490776
Study of Oral LBH589 in Adult Participants With Refractory/Resistant Cutaneous T-Cell Lymphoma (CTCL) treatment 2 terminated NCT06382844
Novel Flow-cytometry Approaches to Improve the Detection of Tumor Cells in CTCL No drug interventions Not Available Not Available recruiting NCT03563040
Study of Photopheresis in the Treatment of Erythrodermic MF and SS treatment 2 withdrawn NCT01445340
Topical Romidepsin to Treat Early-Stage Cutaneous T-Cell Lymphoma treatment 1 terminated NCT00419367
Compassionate Use of Vorinostat for the Treatment of Patients With Advanced Cutaneous T-Cell Lymphoma (0683-042) Not Available Not Available no_longer_available NCT05333367
MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy No drug interventions basic_science Not Available unknown_status NCT05296304
A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides treatment 1 recruiting NCT06120504
A Safety Study of SGN-35T in Adults With Advanced Cancers No drug interventions treatment 1 recruiting NCT00177268
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research No drug interventions Not Available Not Available recruiting NCT01187446
Low-dose (12 Gy) TSEBT+Vorinostat Versus Low-dose TSEBT Monotherapy in Mycosis Fungoides treatment 1 / 2 terminated NCT02448381
FLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides) treatment 3 completed NCT00425555
Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma treatment 2 completed NCT01196208
A Treatment-Option Protocol to Provide Brentuximab Vedotin to Eligible Patients Completing Studies SGN35-005 or C25001 Not Available Not Available no_longer_available NCT02643303
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers treatment 1 / 2 completed NCT00177190
In Vitro Evaluation of Immune Responses in Cutaneous T-Cell Lymphoma (CTCL) No drug interventions Not Available Not Available completed NCT01637090
Everolimus in Treating Cutaneous T-cell Lymphoma treatment 2 terminated NCT03789864
Biodynamic Imaging Utility in Predicting Response to Gemcitabine Chemotherapy in Mycosis Fungoides No drug interventions device_feasibility Not Available terminated NCT03902184
IPH4102 Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma treatment 2 active_not_recruiting NCT00274651
A Phase II Clinical Trial of PXD101 in Patients With Recurrent or Refractory Cutaneous and Peripheral T-Cell Lymphomas treatment 2 terminated NCT02840747
Tissue Repository: CTCL Collection Protocol No drug interventions Not Available Not Available recruiting NCT05137847
A Study of Remitoro in Participants With Recurrent or Refractory Peripheral T Cell Lymphoma and Cutaneous T Cell Lymphoma (All Case Study) Not Available Not Available completed NCT02296398
Long-term Use of Romidepsin in Patients With CTCL Not Available Not Available completed NCT00211198
Study of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL) treatment 4 completed NCT01728805
Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL treatment 3 completed NCT02512497
Romidepsin Maintenance After Allogeneic Stem Cell Transplantation treatment 1 unknown_status NCT00412997
LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell Lymphoma treatment 1 completed NCT00051597
A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic Malignancies treatment 1 / 2 completed NCT01556828
Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing No drug interventions Not Available Not Available terminated NCT00896493
Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma treatment 2 completed NCT00071071
Clinical Trial of HuMax-CD4, a New Drug to Treat Early Stage T-Cell Lymphoma in the Skin. treatment 2 completed NCT02341209
Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma treatment 2 terminated NCT00091559
Oral SAHA (Suberoylanilide Hydroxamic Acid) in Advanced Cutaneous T-cell Lymphoma (0683-001) treatment 2 completed NCT02323659
Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas treatment 4 terminated NCT00050999
Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients treatment 4 completed NCT06385522
A Clinical Trial in Adults With Non-Hodgkin Lymphoma (NHL), With a Particular Emphasis on Cutaneous T Cell Lymphoma (CTCL), Testing the Safety and Activity of a Novel Drug to Inhibit a Protein Called Tumor Necrosis Factor Receptor 2 That Drives Both Lymphoma Growth and Escape of the Immune System No drug interventions treatment 1 not_yet_recruiting NCT05781386
A Phase I Trial of SIM1811-03 in Subjects With Advanced Tumors treatment 1 recruiting NCT04014374
Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab No drug interventions Not Available Not Available recruiting NCT03932279
Characterization of the Microbiome in Cutaneous T Cell Lymphoma No drug interventions Not Available Not Available recruiting NCT03602157
Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL treatment 1 recruiting NCT03385226
A Trial Assessing the Effect of Pembrolizumab Combined With Radiotherapy in Patients With Relapsed, Refractory, Specified Stages of Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides (MF)/Sezary Syndrome (SS) treatment 2 active_not_recruiting NCT03340155
Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases No drug interventions other Not Available unknown_status NCT02576496
Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies treatment 1 completed NCT02546440
Study on Therapy With Dimethylfumarate (DMF) in Patients With Cutaneous T Cell Lymphoma (CTCL) treatment 2 completed NCT01569724
Carbohydrate Metabolism Disorder Frequency in Hypertriglyceridemia Induced by Bexarotene of Cutaneous T Cell Lymphoma No drug interventions treatment 4 completed NCT01198665
RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell Lymphomas treatment 1 / 2 completed NCT00178841
Combination Drug Study of Bexarotene and Rosiglitazone to Treat CTCL treatment 2 completed NCT03357224
PARCT: Trial of Atezolizumab in Relapsed/Refractory Cutaneous T Cell Lymphoma (CTCL) treatment 2 terminated NCT00699296
Study of Oral LBH589 in Patients With Cutaneous T-cell Lymphoma and Adult T-cell Leukemia/Lymphoma treatment 2 terminated NCT04296786
Sintilimab Plus Chidamide in the Treatment of Relapsed and Refractory Cutaneous T-cell Lymphoma: a Multicenter Phase II Study treatment 2 recruiting NCT00038025
A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies treatment 2 completed NCT00043420
CPG 7909 in Patients With Cutaneous T-Cell Lymphoma treatment 1 / 2 completed NCT00106431
A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-cell Lymphoma (CTCL) treatment 2 completed NCT04447027
Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies treatment 1 active_not_recruiting NCT00554827
Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma treatment 1 completed NCT00744991
A Study for Participants With Relapsed Cutaneous T-Cell Lymphoma treatment 2 completed NCT05106192
Triamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System. supportive_care Not Available not_yet_recruiting NCT02953301
Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS) treatment 2 completed NCT03742804
Study Of Intratumoral G100 In Cutaneous T Cell Lymphoma No drug interventions treatment 2 withdrawn NCT01226472
Extension Study in Subjects Who Relapsed After Complete Response on Study KW-0761-001 treatment 2 completed NCT00306969
Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma treatment 1 / 2 completed NCT00051012
Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients treatment 4 completed NCT00431912
A Study of APO866 for the Treatment of Cutaneous T-cell Lymphoma treatment 2 completed NCT02039895
Helical Irradiation of Total Skin (HITS) for Cutaneous Lymphoma No drug interventions treatment Not Available unknown_status NCT00863395
Recalcitrant Pruritus in Cutaneous T-Cell Lymphoma No drug interventions diagnostic 1 / 2 terminated NCT03192202
AFM13 in Relapsed/Refractory Cutaneous Lymphomas treatment 1 / 2 completed NCT00071084
Clinical Trial of HuMax-CD4, a New Drug to Treat Advanced Stage T-Cell Lymphoma in the Skin. treatment 2 completed NCT03617224
Pembrolizumab and Total Skin Electron Beam Radiotherapy in Mycosis Fungoides and Sézary Syndrome treatment 1 withdrawn NCT00476554
A Randomized Phase II Study of Oral Sapacitabine in Patients With Advanced Cutaneous T-cell Lymphoma treatment 2 terminated NCT02314247
Efficacy and Safety Study of Selinexor in Relapsed or Refractory Peripheral T-cell Lymphoma or Cutaneous T-cell Lymphoma treatment 2 terminated NCT02213861
Efficacy, Safety and Tolerability Study of SHAPE in IA, IB or IIA Cutaneous T-cell Lymphoma treatment 2 unknown_status NCT06485219
A Phase IIa Clinical Study of Puesta Mesylate for Injection in Patients With T-Cell Lymphoma and Cutaneous T-Cell Lymphoma No drug interventions treatment 2 recruiting NCT05569057
A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma No drug interventions treatment 1 recruiting NCT02616965
A Study to Assess the Feasibility of Romidepsin Combined With Brentuximab Vedotin in Cutaneous T-cell Lymphoma treatment 1 active_not_recruiting NCT00611208
A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL) treatment 2 completed NCT01843998
Therapeutic Efficacy of Topical Sirolimus in Early Stage Cutaneous T-cell Lymphoma (CTCL) treatment 2 withdrawn NCT02580552
Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL treatment 1 completed NCT01396070
Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level treatment 2 completed NCT04072458
A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies No drug interventions treatment 1 recruiting NCT00501735
Forodesine in the Treatment of Cutaneous T-Cell Lymphoma treatment 2 completed NCT05156229
A Phase 1/2a Study of CDK-003 in Patients With Cutaneous T-Cell Lymphoma (CTCL). No drug interventions treatment 1 terminated NCT05225584
Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors treatment 1 recruiting NCT03240211
Study of Pembrolizumab Combined With Decitabine and Pralatrexate in PTCL and CTCL treatment 1 recruiting NCT02757248
Ph1 Volasertib Plus Romidepsin in R/R PTCL and CTCL treatment 1 withdrawn NCT04171791
A Study of ABT-199 (Venetoclax) for Cutaneous T Cell Lymphoma (CTCL) treatment 1 completed NCT05879458
Ritlecitinib in CTCL treatment 2 recruiting NCT02556463
A Study of MEDI9197 in Subjects With Solid Tumors or CTCL and in Combination With Durvalumab and/or Palliative Radiation in Subjects With Solid Tumors treatment 1 terminated NCT04087629
StrataCTX® as a Steroid Sparing Device No drug interventions supportive_care Not Available recruiting NCT03239392
A Dose-Ranging Study of IV BNZ-1 in LGL Leukemia or Refractory CTCL treatment 1 / 2 completed